Sarah E. Hopwood, Catarina A. Owesson, Luis F. Callado, Daniel P. McLaughlin, and Jonathan A. Stamford

Effects of chronic tramadol on pre- and post-synaptic measures of monoamine function
J Psychopharmacol 2001 15: 147-153. [Abstract] [PDF] [References] [Request Permission]  

Paavo Pokk and Marika Väli

The effects of flumazenil, Ro 15-4513 and β-CCM on the behaviour of control and stressed mice in the staircase test
J Psychopharmacol 2001 15: 155-159. [Abstract] [PDF] [References] [Request Permission]  

David S. Baldwin, Christopher J. Hawley, and Karen Mellors On behalf of the CN104-070 study group

A randomized, double-blind controlled comparison of nefazodone and paroxetine in the treatment of depression: safety, tolerability and efficacy in continuation phase treatment
J Psychopharmacol 2001 15: 161-165. [Abstract] [PDF] [References] [Request Permission]  

C. R. Gordon, A. Gonen, Z. Nachum, I. Doweck, O. Spitzer, and A. Shupak

The effects of dimenhydrinate, cinnarizine and transdermal scopolamine on performance
J Psychopharmacol 2001 15: 167-172. [Abstract] [PDF] [References] [Request Permission]  

Jeroen A. J. Schmitt, Monique J. Kruizinga, and Wim J. Riedel

Non-serotonergic pharmacological profiles and associated cognitive effects of serotonin reuptake inhibitors
J Psychopharmacol 2001 15: 173-179. [Abstract] [PDF] [References] [Request Permission]  

N. MacInnes, S. L. Handley, and G. F. A. Harding

Former chronic methylenedioxymethamphetamine (MDMA or ecstasy) users report mild depressive symptoms
J Psychopharmacol 2001 15: 181-186. [Abstract] [PDF] [References] [Request Permission]  

Kamini Vasudev, Saurendra Das, Utpal Goswami, and Girish Tayal

Pharmacokinetics of valproic acid in patients with bipolar disorder
J Psychopharmacol 2001 15: 187-190. [Abstract] [PDF] [References] [Request Permission]  

J. M. Delieu, M. Badawoud, M. A. Williams, R. W. Horobin, and J. K. Duguid

Antipsychotic drugs result in the formation of immature neutrophil leucocytes in schizophrenic patients
J Psychopharmacol 2001 15: 191-194. [Abstract] [PDF] [References] [Request Permission]  

Wai S. Tse and Alyson J. Bond

Serotonergic involvement in the psychosocial dimension of personality
J Psychopharmacol 2001 15: 195-198. [Abstract] [PDF] [References] [Request Permission]  

Désirée B. Oosterbaan, Anton J. L. M. van Balkom, Philip Spinhoven, and Richard van Dyck

The placebo response in social phobia
J Psychopharmacol 2001 15: 199-203. [Abstract] [PDF] [References] [Request Permission]  

J. J. Sandford, S. Forshall, C. Bell, S. Argyropoulos, A. Rich, K. J. D'Orlando, R. E. Gammans, and D. J. Nutt

Crossover trial of pagoclone and placebo in patients with DSM-IV panic disorder
J Psychopharmacol 2001 15: 205-208. [Abstract] [PDF] [References] [Request Permission]  

Jaydip Sarkar, Neil Jones, and Gary Sullivan

A case of depersonalization–derealization syndrome during treatment with quetiapine
J Psychopharmacol 2001 15: 209-211. [Abstract] [PDF] [References] [Request Permission]  

E. J. Harvey, D. M. Taylor, and R. J. Flanagan

D2 receptor occupancy under recommended and high doses of olanzapine
J Psychopharmacol 2001 15: 213. [PDF] [References] [Request Permission]  

E. M. Meisenzahl, G. J. E. Schmitt, S. Dresel, and H. -J. Möller

Reply to E. J. Harvey et al. — D2 receptor occupancy under recommended and high doses of olanzapine
J Psychopharmacol 2001 15: 214. [PDF] [References] [Request Permission]  

To see an article, click its [PDF] link. To add articles to your marked citations, check the boxes to the left of the titles you want, and click the 'Add to Marked Citations' button. To see one abstract at a time, click its [Abstract] link.